** Shares of healthcare firm Organon OGN.N fall 8% to $7.07 premarket
**Co posts Q4 adj. profit of 63 cents/shr, below estimates of 73 cents/shr - LSEG estimates
** OGN posts Q4 revenue of $1.5 billion, compared to estimates of $1.54 billion
** OGN stock was down ~52% in 2025
(Reporting by Gnaneshwar Rajan in Bengaluru)
((Gnaneshwar.Rajan@thomsonreuters.com;))